The long-term goal of this project is to characterize the regulation of gene expression at the translational level. As the applicant's model system, he will investigate the regulation of expression of thymidylate synthase (TS), a critical target in cancer chemotherapy. This enzyme catalyzes the folate-dependent reductive methylation reaction which provides for the sole intracellular de novo source of thymidylate, a key precursor for DNA biosynthesis, and thus, TS plays a central role in maintaining the metabolic requirements of the cell. Previous studies from his laboratory have shown that in addition to its role in catalysis and cellular metabolism, TS also functions as an RNA binding protein. TS binds with high affinity (1-3nM) to two different sites on its own TS mRNA, with one site located in the 5'-untranslated region and the second site in the protein-coding region. This RNA-protein interaction results in the translational repression of TS mRNA with subsequent inhibition of synthesis of new TS protein. Thus, the model of TS translational autoregulation would appear to be biologically relevant in that it offers a rational mechanism for the tight control of TS expression within a given cell. However, treatment of TS protein with inhibitor compounds such as FdUMP or the antifolate inhibitor D1694 alters the normal TS protein-TS mRNA interaction resulting in enhanced translational efficiency of TS mRNA and an increased synthesis of new TS protein. Disruption of this regulatory process might provide an efficient mechanism for malignant cells to protect themselves in response to exposure to cytotoxic stress. To further understanding of the molecular elements underlying the translational regulation of TS, two specific aims are proposed in this project: (1) Characterize the critical cis-acting elements on the TS mRNA that are required for the TS mRNA-TS protein interaction. The applicant plans to identify the essential nucleotide sequences and/or secondary structural elements required for protein recognition of both the 5'-upstream and protein-coding region binding sites, and (2) Characterize the critical trans-acting elements on the TS protein that are necessary for RNA recognition. Specifically, the applicant plans to identify the domain or domains on the TS protein as well as the critical amino acid contact points that mediate the process of RNA binding.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA075712-02
Application #
2769978
Study Section
Special Emphasis Panel (ZRG2-ET-2 (01))
Program Officer
Johnson, George S
Project Start
1997-09-18
Project End
2000-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Tai, Ningwen; Schmitz, John C; Chen, Tian-Min et al. (2008) Identification of a cis-acting element of human dihydrofolate reductase mRNA. Biochem Biophys Res Commun 369:795-800
Ju, Jingfang; Schmitz, John C; Song, Bo et al. (2007) Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells. Clin Cancer Res 13:4245-51
Tai, Ningwen; Schmitz, John C; Liu, Jun et al. (2004) Translational autoregulation of thymidylate synthase and dihydrofolate reductase. Front Biosci 9:2521-6
DiPaolo, Antontello; Chu, Edward (2004) The role of thymidylate synthase as a molecular biomarker. Clin Cancer Res 10:411-2
Schmitz, John C; Chen, Tian-min; Chu, Edward (2004) Small interfering double-stranded RNAs as therapeutic molecules to restore chemosensitivity to thymidylate synthase inhibitor compounds. Cancer Res 64:1431-5
Tai, Ningwen; Schmitz, John C; Chen, Tian-min et al. (2004) Characterization of a cis-acting regulatory element in the protein-coding region of human dihydrofolate reductase mRNA. Biochem J 378:999-1006
Chu, Edward; Callender, Marc A; Farrell, Michael P et al. (2003) Thymidylate synthase inhibitors as anticancer agents: from bench to bedside. Cancer Chemother Pharmacol 52 Suppl 1:S80-9
Lin, Xiukun; Liu, Jun; Maley, Frank et al. (2003) Role of cysteine amino acid residues on the RNA binding activity of human thymidylate synthase. Nucleic Acids Res 31:4882-7
Rose, Michal G; Farrell, Michael P; Schmitz, John C (2002) Thymidylate synthase: a critical target for cancer chemotherapy. Clin Colorectal Cancer 1:220-9
Liu, Jun; Schmitz, John C; Lin, Xiukun et al. (2002) Thymidylate synthase as a translational regulator of cellular gene expression. Biochim Biophys Acta 1587:174-82

Showing the most recent 10 out of 20 publications